Skip to main content
Equibles

MORGAN STANLEY

Position in TLX — Telix Pharmaceuticals Ltd

CIK 895421 NEW YORK, NY
Back to TLX Full portfolio

Position in TLX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,913,725
+$799,395 QoQ
Shares Held
165,978
+42.5% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 62 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in TLX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. TLX ranks #217 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in TLX

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,913,725 165,978
2026-03-31 $1,114,330 116,440
2025-12-31 $132,220 17,653
2025-09-30 $30,949 3,234
2025-06-30 $70,739 4,402
2025-03-31 $94,425 5,634